Today: 30 April 2026
Browse Category

NYSE:IREN 11 January 2026 - 23 April 2026

IREN Stock Jumps as AI Cloud Bet Meets $6 Billion Dilution Test

IREN Stock Jumps as AI Cloud Bet Meets $6 Billion Dilution Test

IREN shares jumped 7.3% to $51.94 in New York Thursday amid debate over its shift from bitcoin mining to AI cloud services. The company plans to deploy 150,000 Nvidia GPUs by late 2026 and reported $2.8 billion in cash as of January. AI cloud revenue remains small compared to bitcoin mining, with $17.3 million last quarter. IREN can sell up to $6 billion in stock under a new SEC filing.
23 April 2026
···
IREN stock price jumps as traders lean back into AI-cloud bet despite bitcoin slide

IREN stock price jumps as traders lean back into AI-cloud bet despite bitcoin slide

IREN shares climbed 6.4% to $44.51 Monday, rebounding after last week’s earnings drop despite a decline in bitcoin. The company reported a quarterly net loss of $155.4 million on $184.7 million in revenue, with $167.4 million from bitcoin mining and $17.3 million from AI services. IREN said it secured $3.6 billion in GPU financing tied to its Microsoft contract. Analyst price targets diverged after the results.
9 February 2026
······
IREN stock: what to watch before Monday after Bernstein tags it “top AI pick”

IREN stock: what to watch before Monday after Bernstein tags it “top AI pick”

IREN Limited closed up 0.7% at $46.03 after Bernstein named it a top AI pick for 2026, citing bitcoin’s apparent bottom. Bitcoin traded near $90,473, with crypto-linked stocks mixed. IREN’s recent $9.7 billion Microsoft cloud deal and $5.8 billion Dell hardware agreement remain in focus. The U.S. December CPI report is due Tuesday, with the Fed meeting set for Jan. 27-28.
11 January 2026
·

Stock Market Today

  • Why Investors Are Focused on Vaidya Sane Ayurved Laboratories (NSE:MADHAVBAUG) Amid Growth and High Insider Ownership
    April 29, 2026, 10:29 PM EDT. Vaidya Sane Ayurved Laboratories (NSE:MADHAVBAUG) has attracted investor attention due to its strong financial performance and insider alignment. The company has delivered a compound annual EPS growth of 19% over the past three years, signaling sustained earnings momentum. Revenue growth and an improved EBIT margin, up by 6.6 percentage points to 11%, underscore operational strength. With insiders owning 78% of the firm, alignment between management and shareholders is notably high, reducing agency risk. Valued at ₹2.5 billion, the company appeals to investors favoring profitable, growing firms over speculative ventures without revenue or profit history. This combination of growth, profitability, and insider confidence makes Vaidya Sane a compelling pick in the Ayurvedic healthcare sector.

Latest article

Soluna Holdings Stock Jumps After Sazmining Bitcoin Deal, Then SEC Resale Filing Lands

Soluna Holdings Stock Jumps After Sazmining Bitcoin Deal, Then SEC Resale Filing Lands

30 April 2026
Soluna Holdings filed to register the resale of about 2.46 million common shares, with no proceeds going to the company. The move follows Sazmining’s launch of a 3-megawatt Bitcoin mining operation at Soluna’s Project Dorothy 1B in West Texas. Soluna shares last traded at $1.28, up from a $1.08 Nasdaq sale price on April 28. The registered shares include 2.4 million issuable to YA II PN, LTD. via warrant exercise.
Brookfield Renewable Stock Drops 12% Before Q1 Results as BEPC Investors Brace for Friday

Brookfield Renewable Stock Drops 12% Before Q1 Results as BEPC Investors Brace for Friday

30 April 2026
Brookfield Renewable Corp’s NYSE shares fell 12.5% to $35.20 on Wednesday, with volume quadrupling the three-month average ahead of first-quarter results due Friday. The drop came despite a higher quarterly dividend and mixed analyst views. The company operates 47 GW of clean energy assets globally. Analysts expect a first-quarter loss of 33.92 cents per share on $1.62 billion in revenue.
Go toTop